BH-F Stock Overview
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Bumrungrad Hospital Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿254.00 |
| 52 Week High | ฿266.00 |
| 52 Week Low | ฿211.00 |
| Beta | 0.21 |
| 1 Month Change | 11.40% |
| 3 Month Change | 5.39% |
| 1 Year Change | n/a |
| 3 Year Change | 103.20% |
| 5 Year Change | 43.50% |
| Change since IPO | 1,761.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| BH-F | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 11.4% | 0.7% | 0.2% |
| 1Y | n/a | -5.2% | -11.0% |
Return vs Industry: Insufficient data to determine how BH-F performed against the TH Healthcare industry.
Return vs Market: Insufficient data to determine how BH-F performed against the TH Market.
Price Volatility
| BH-F volatility | |
|---|---|
| BH-F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in TH Market | 9.3% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: BH-F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BH-F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | n/a | Artirat Charukitpipat | www.bumrungrad.com |
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics.
Bumrungrad Hospital Public Company Limited Fundamentals Summary
| BH-F fundamental statistics | |
|---|---|
| Market cap | ฿201.91b |
| Earnings (TTM) | ฿7.41b |
| Revenue (TTM) | ฿26.02b |
27.3x
P/E Ratio7.8x
P/S RatioIs BH-F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BH-F income statement (TTM) | |
|---|---|
| Revenue | ฿26.02b |
| Cost of Revenue | ฿12.89b |
| Gross Profit | ฿13.13b |
| Other Expenses | ฿5.72b |
| Earnings | ฿7.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 08, 2024
| Earnings per share (EPS) | 9.32 |
| Gross Margin | 50.46% |
| Net Profit Margin | 28.47% |
| Debt/Equity Ratio | 0.1% |
How did BH-F perform over the long term?
See historical performance and comparison